# Marc DeCongelio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-decongelio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 4 |
| i10-index | 1 |
| Last Known Institution | Oracle (United States) |
| OpenAlex ID | https://openalex.org/A5035941290 |
| ORCID iD | 0009-0004-5486-5584 |
| Works | 42 |

## Researcher papers

- [Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (<scp>POWER</scp>) study](https://scholariq.org/papers/quantifying-the-impact-of-symptomatic-acute-hepatic-porphyria-on-well-being-via/)
- [Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment](https://scholariq.org/papers/treatment-preferences-among-patients-with-renal-cell-carcinoma-results-from-a/)
- [A global perspective in <scp>second‐line</scp> treatment patterns for patients with advanced esophageal squamous cell carcinoma](https://scholariq.org/papers/a-global-perspective-in-scp-second-line-scp-treatment-patterns-for-patients-with/)
- [The incidence and prevalence of immunoglobulin A nephropathy in the United States](https://scholariq.org/papers/the-incidence-and-prevalence-of-immunoglobulin-a-nephropathy-in-the-united/)
- [Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data](https://scholariq.org/papers/effectiveness-of-tolvaptan-for-autosomal-dominant-polycystic-kidney-disease-in/)
- [First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment.](https://scholariq.org/papers/first-line-treatment-preferences-for-advanced-melanoma-among-oncologists-and/)
- [Chi-Square Automatic Interaction Detection (CHAID) Analysis: Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy](https://scholariq.org/papers/chi-square-automatic-interaction-detection-chaid-analysis-understanding-and/)
- [HSR21-055: Treatment Patterns and Healthcare Resource Utilization in First-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma in Asian and Western Countries](https://scholariq.org/papers/hsr21-055-treatment-patterns-and-healthcare-resource-utilization-in-first-line/)
- [P39 The Humanistic Burden of Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes on Patients and Caregivers: Qualitative Research Findings](https://scholariq.org/papers/p39-the-humanistic-burden-of-transfusion-dependent-lower-risk-myelodysplastic/)
- [Understanding “Wearing-off” in patients receiving calcitonin gene-related peptide pathway monoclonal antibodies for the preventive treatment of migraine](https://scholariq.org/papers/understanding-wearing-off-in-patients-receiving-calcitonin-gene-related-peptide/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Researcher university

- [Oracle (United States)](https://scholariq.org/institutions/oracle-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.